Big babies and infant leukemia: A role for insulin-like growth factor-1?

Cancer Causes and Control

Volumn 7, Issue 5, 1996, Pages 553-559

  Ross, Julie A ^a   Perentesis, John P ^a   Robison, Leslie L ^a   Davies, Stella M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Birthweight; Childhood; IGF 1; Infant; Leukemia

Indexed keywords

SOMATOMEDIN C;

BIRTH WEIGHT; CHILDHOOD LEUKEMIA; HUMAN; HYPOTHESIS; INFANT; PRIORITY JOURNAL; REVIEW;

EID: 0029833247     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051889     Document Type: Review

References (66)

1. MacMahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. JNCI 1962; 28: 231-44.
2. Iversen T. Leukaemia in infancy and childhood. A material of 570 Danish cases. Acta Paediatr Scand[Suppl] 1966; 167:25-50.
3. Jackson EW, Norris FD, Klauber MR. Childhood leukemia in California-born twins. Cancer 1968; 23: 913-9.
4. Fasal E, Jackson EW, Klauber MR. Birth characteristics and leukemia in childhood. JNCI 1971; 47: 501-9.
5. Wertelecki W, Mantel N. Increased birthweight in leukemia. Pediatr Res 1973; 7: 132-8.
6. Hirayma T. Descriptive and analytical epidemiology of child-hood malignancy in Japan. In: Kobayashi N, ed. Recent Advances in Management of Children With Cancer. Tokyo, Japan: The Children's Cancer Association of Japan, 1980; 27-43.
7. Daling JR, Starzyk P, Olshan AF, Weiss NS. Birthweight and the incidence of childhood cancer. JNCI 1984; 72:1039-41.
8. Shaw G, Lavey R, Jackson R, Austin D. Association of childhood leukemia with maternal age, birth origin, and paternal occupation. Am J Epidemiol 1984; 119: 788-95.
9. Eisenberg DE, Sorahan T. Birthweight and childhood cancer deaths. JNCI 1987; 78: 1095-100.
10. Shu XO, Gao YT, Brinton LA, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988; 62: 635-44.
11. Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP. Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 1991; 68: 1351-5.
12. Savitz DA, Ananth CV. Birth characteristics of childhood cancer cases, controls, and their siblings. Ped Hematol Oncol 1994; 11: 587-99.
13. Cnattingius S, Zack MM, Ekbom A, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. JNCI 1995; 87: 908-14.
14. Cnattingius S, Zack MM, Ekbom A, et al. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biom Prev 1995; 4: 441-5.
15. Ross JA, Potter JD, Shu XO, Reaman GH, Lampkin B, Robison LL. Evaluating the relationships among maternal reproductive history, birth weight, and risk of infant leukemia. A report from the Childrens Cancer Group. Ann Epidemiol (in press).
16. Yeazel MW, ROSS JA, Buckley JD, Woods WG, Ruccione K, Robison LL. High birthweight and risk of specific child-hood cancers: a report from the Children's Cancer Group. (Submitted).
17. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-95.
18. Ross JA, Davies SM, Potter JD, Robison LL. The epidemiology of childhood leukemia with a focus on infants. Epidemiologic Rev 1994; 16: 243-72.
19. LeisenringWM, Breslow NE, Evans IE, Beckwith JB, Coppes MJ, Grundy P. Increased birthweights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res 1994; 54: 4680-3.
20. Weksberg R, Shen DR, Fei YL, Song QL, SquireJ. Disruption of insulin-like growth factor 2 imprinting in BeckwithWiedemann Syndrome. Nat Genet 1993; 5: 143-50.
21. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulinlike growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749-51.
22. Olshan AF. Wilms' tumor, overgrowth, and fetal growth factors. A hypothesis. Cancer Genet Cytogen 1986; 21:303-7.
23. Insulin-like growth factors. In: Pimentai E, ed. Handbook of Growth Factors. Vol II. Peptide Growth Factors. Boca Raton, FL (USA): CRC Press, Inc., 1994; 55-95.
24. Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994; 42: 140-4.
25. Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocinol Metab 1983; 57: 609-12.
26. Gluckman PD, Johnson-Barrett JJ, Butler JH, Edgar BW, Gunn TR. Studies of insulin-like growth factor-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrin 1983; 19: 405-13.
27. Ashton IK, Zapf J, Einschenk I, MacKenzie IZ. Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinologica 1985; 110: 558-63.
28. Samaan NA, Schultz PN, Johnston DA, Creasy RW, Gonik B. Growth hormone, somatomedin C, and nonsuppressible insulin-like activity levels compared in premature, small, average birth weight, and large infants. Am J Obstet Gynecol 1987; B;157: 1524-8.
29. Lasarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulinlike growth factor binding proteins in the human fetus. Relationships with growth in normal subjects with intrauterine growth retardation. Ped Res 1991; 29: 219-25.
30. Salardi S, Orsini LF, Cacciari F, Righetti F, Donati S, Mandini M. Growth hormone, insulin-like growth factor I, insulin and C-peptide during human fetal life: in-utero study. Clin Endocrinol 1991; 34: 187-90.
31. Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endrocrinol 1991; 129: 459-64.
32. Delmis J, Drazancic A, Ivanisevic M, Suchanek E. Glucose, insulin, HGH, and IGF-1 levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J Perinat Med 1992; 20: 47-56.
33. Kubota T, Kamada S, Taguchi M, Aso T. Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinologica 1992; 127:359-65.
34. Fant M, Salafia C, Baxter RC, et al. Circulating levels of IGFs and IGF binding proteins in human cord serum. Relationships to intrauterine growth. Regulatory Pef tides 1993; 48: 29-39.
35. Verhaeghe J, Van Bree R,Van Herck EV, Laureys J, Bouillon R, Van Assch FA. C-pepride, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993; 169: 89-97.
36. Reece EA, Wiznitzer A, Le E, Homko CJ, Behram H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 1994; 84: 88-95.
37. Simmons D. Interrelation between umbilical cord serum sex hormones, sex hormone-binding globulin, insulin-like growth factor 1, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes. J Clin Endocrinol Metab 1995; 80: 2217-21.
38. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82.
39. Perentesis JP, Kersey JH. Biologic therapy in leukemia. In: Henderson ES, Lister TA, Greaves MF, eds. Leukemia, 6th Ed. London, UK: WB Saunders, 1996.
40. Baier TG, Jenne EW, Blum W, Shonberg D, Hartmann KK. Influence of antibodies against IGF-1, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines. Leuk Res 1993; 16: 807-14.
41. Sanders M, Sorba S, Daniak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exper Hematol 1993; 21: 25-30.
42. Jardieu P, Clark R, Mortensen D, Dorshkind K. In vivo ad ministration of insulin-like growth factor-1 stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol 1994; 152: 4320-7.
43. Estrov Z, Meir R, Barak Y, Zaizov R, Zadik Z. Human growth hormone and IGF-1 enhances the proliferation of leukemic blasts. J Clin Oncol 1991; 9: 394-9.
44. Shimon I, Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res 1995; 19: 233-40.
45. Knudson AG, Meadows AT, Nichols WW, Hill R. Chromosomal deletion and retinoblastoma. N EnglJ Med 1976; 295: 1120-3.
46. Volgelstein V, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
47. Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995; 85: 2528-36.
48. Nucifora G, Larson RH, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long term remission. Blood 1993; 82: 712-5.
49. Morris JA. A mutarional theory of leukemogenesis. J Clin Pathol 1989; 42: 337-40.
50. Wasserman R, Galili N, Ito Y, Reichard BA, Shane S, Rovera G. Predominance of fetal type DJH joining in young children with B-precursor lymphoblastic leukemia as evidence for an in utero transforming event. J Exper Med 1992; 176: 1577-81.
51. Steenbergen EJ, Verhagen OJ, Van Leeuwen EF, et al. B-precursor acute lymphoblastic leukemia third complementarily determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Euro J Immunol 1994; 24: 900-8.
52. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukemias. Nature 1993; 363: 358-60.
53. Mahmoud HH, Ridge SA, Behm, FG, et aL Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. Med Ped Oncol 1995; 24: 77-81.
54. Greaves MJ, Chan LC. Is spontaneous mutation the major 'cause' of childhood acute lymphoblastic leukemia? Br J Hematol 1986; 64: 1-13.
55. Metcalf D, Rasko JEJ. Leukemic transformation of immortalized FDC-Pl engrafted in GM-CSF transgenic mice. Blood 1993; 7: 878-86.
56. Cannistra SA, Groshak P, Griffin JD. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myelogenous leukemia. Leukemia 1989; 3: 328-34.
57. Buchner T, Hiddemann W, Koenigsmann M, et al. Recombinant human granulocyte-macrophage colony stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age after relapse. Blood 1991; 78: 1190-7.
58. Ganser A, Volkers B, Greher J, et al Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplasric syndromes - a phase I/II trial. Blood 1989; 73: 31-7.
59. Herrmann F, Lindemann A, Klein H, Lubbert M, Shulz G, Mertelsmann R. Effect of recombinant human granulocytemacrophage colony-stimulating factor in patients with myelodysplasric syndrome with excess blasts. Leukemia 1989; 31: 335-8.
60. Williams GT, Smith CA. Molecular regulation of apoptosis. genetic controls on cell death. Cell 1993; 74: 777-9.
61. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-42.
62. Pui CH, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4; 11)(q21;q23). A collaborative study of 40 cases. Blood 1991; 77: 440-7.
63. Neiman PE, Thomas SJ, Loring G. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricus. Proc Natl Acad Sci USA 1991; 88:5857-61.
64. Muta K, Krantz SB. Apoptosis of human erythroid colonyforming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 1993; 156: 264-71.
65. Reaman G, Zeltzer P, Bleyer WA, et al. Acute lymphoblastic leukemia in infants less than one year of age. A cumulative experience of the Childrens Cancer Study Group. Blood 1985; 3: 1513-21.
66. Department of Health and Human Services. Compilations of Data on Natality, Mortality, Marriage, Divorce, and Induced Terminations of Pregnancy. No 1. Hyattsville, MD (USA): DHHS, May 1989; DHHS Publication No. (PHS) 89-1951, Vital and Health Statistics Supplements to the Monthly Vital Statistics Report. Series 24.